Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001
Symbol
CDLX on Nasdaq
Shares outstanding
53,041,500
Price per share
$1.22
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
11,216,179
Total reported value
$12,898,816
% of total 13F portfolios
0%
Share change
-594,908
Value change
-$762,470
Number of holders
42
Price from insider filings
$1.22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CAS Investment Partners, LLC 9.8% -11% $10,656,037 -$854,463 5,198,067 -7.4% CAS Investment Partners, LLC 19 Aug 2025
VANGUARD GROUP INC 4.6% $3,975,815 2,416,909 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 2.1% $1,810,565 1,098,977 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 42 institutional investors reported holding 11,216,179 shares of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX). This represents 21% of the company’s total 53,041,500 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) together control 21% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.9% 2,609,787 +8.7% 0% $3,001,255
KPS Global Asset Management UK Ltd 2.3% 1,218,830 0% 0.17% $1,401,655
WORLDLY PARTNERS MANAGEMENT, LLC 2.2% 1,157,989 0% 0.99% $1,331,687
BlackRock, Inc. 1.8% 966,223 -0.55% 0% $1,111,157
JANE STREET GROUP, LLC 1.2% 658,784 -18% 0% $757,601
GEODE CAPITAL MANAGEMENT, LLC 1.2% 654,472 +3.3% 0% $752,873
JACOBS LEVY EQUITY MANAGEMENT, INC 1.2% 638,617 0% $734,410
CITIZENS FINANCIAL GROUP INC/RI 0.91% 483,000 -6.9% 0.01% $555,450
GSA CAPITAL PARTNERS LLP 0.89% 470,350 +313% 0.05% $541,000
Quinn Opportunity Partners LLC 0.87% 462,402 -58% 0.02% $531,762
LPL Financial LLC 0.84% 445,387 -5.3% 0% $512,195
STATE STREET CORP 0.43% 227,731 0% 0% $261,891
SIMPLEX TRADING, LLC 0.35% 186,379 -27% 0.01% $214,335
UBS Group AG 0.35% 185,751 -59% 0% $213,613
DIMENSIONAL FUND ADVISORS LP 0.24% 127,228 -39% 0% $146,311
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 0.23% 119,933 -1.2% 0.02% $137,923
GOLDMAN SACHS GROUP INC 0.21% 109,001 +15% 0% $125,351
BROWN ADVISORY INC 0.2% 107,603 -8.5% 0% $123,743
Jefferies Financial Group Inc. 0.16% 86,150 0% 0% $99,073
BARCLAYS PLC 0.11% 55,969 +31168% 0% $64,364
RENAISSANCE TECHNOLOGIES LLC 0.1% 54,000 0% $62,100
GROUP ONE TRADING LLC 0.09% 48,334 -59% 0% $55,584
Global Retirement Partners, LLC 0.09% 45,300 +30% 0% $52,095
Post Resch Tallon Group Inc. 0.04% 20,000 0% 0.02% $23,000
Centiva Capital, LP 0.03% 17,427 -59% 0% $20,041

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 11,216,179 $12,898,816 -$762,470 $1.15 42
2025 Q3 22,781,399 $55,357,566 -$1,193,667 $2.43 81
2025 Q2 24,551,816 $40,388,162 -$6,876,388 $1.64 87
2025 Q1 28,581,930 $52,019,284 -$5,385,568 $1.82 104
2024 Q4 30,318,387 $112,466,107 -$2,088,576 $3.71 105
2024 Q3 30,794,820 $98,563,618 -$20,795,943 $3.20 109
2024 Q2 33,695,414 $276,632,711 -$28,175,400 $8.21 123
2024 Q1 35,620,190 $516,145,298 +$96,938,383 $14.49 141
2023 Q4 29,212,104 $269,093,210 +$5,557,027 $9.21 122
2023 Q3 28,041,297 $463,142,226 +$17,744,620 $16.50 111
2023 Q2 27,412,381 $173,379,558 -$8,554,891 $6.32 107
2023 Q1 28,654,397 $97,285,032 -$6,579,840 $3.40 100
2022 Q4 29,783,293 $172,154,817 -$28,548,438 $5.78 120
2022 Q3 31,554,421 $296,615,241 -$30,189,534 $9.40 119
2022 Q2 31,596,179 $705,114,664 -$47,941,923 $22.31 129
2022 Q1 33,306,573 $1,831,644,508 +$20,984,402 $54.98 148
2021 Q4 32,869,535 $2,172,578,259 +$79,885,779 $66.09 156
2021 Q3 31,254,515 $2,624,187,470 -$77,766,844 $83.94 162
2021 Q2 31,402,934 $3,990,653,437 +$126,270,154 $126.93 189
2021 Q1 29,846,728 $3,274,240,688 +$271,523,652 $109.70 199
2020 Q4 27,784,592 $3,965,954,154 +$70,956,802 $142.77 194
2020 Q3 26,692,394 $1,883,241,294 +$112,252,889 $70.57 162
2020 Q2 25,018,920 $1,750,601,005 +$226,035,991 $69.98 164
2020 Q1 22,440,998 $784,589,581 -$47,809,544 $34.96 141
2019 Q4 23,008,936 $1,446,322,852 +$109,382,347 $62.86 154
2019 Q3 21,246,669 $712,189,095 +$88,173,279 $33.52 117
2019 Q2 19,154,562 $497,359,320 +$81,154,271 $25.98 79
2019 Q1 16,284,415 $269,598,973 +$7,820,714 $16.54 62
2018 Q4 16,111,197 $174,481,975 +$5,332,809 $10.83 61
2018 Q3 11,931,477 $298,164,482 +$47,426,352 $25.04 59
2018 Q2 10,063,300 $217,430,809 +$11,913,905 $21.76 52
2018 Q1 9,791,394 $141,747,708 +$141,747,708 $14.63 51